SIGN UP
LOG IN
B
02315
Biocytogen Pharmaceuticals (Beij…
13.90
2.02+17.00%Closed16:08 05/02 HKT
OPEN/PREV CLOSE11.920/11.880
TODAY RANGE11.900-14.480
VOL195.00K
MARKET CAP5.55B
52 WEEK RANGE5.600-17.300
AVG VOL (3M)261.67K
% TURNOVER0.05%
TURNOVER2.58M
P/E (TTM)153.271
% RANGE21.72%
EPS(TTM)0.091
P/E(FORWARD)-59.250
P/B6.164
BVPS2.255
DIVIDEND--
P/S8.205
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.54B
SHARES OUTSTANDING399.40M
NEXT EARNINGS--
FREE FLOAT110.78M
LOT SIZE500
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·1d ago
We Think Biocytogen Pharmaceuticals (Beijing)'s (HKG:2315) Robust Earnings Are Conservative
Simply Wall St·03/27 23:23
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.'s (HKG:2315) Price Is Right But Growth Is Lacking After Shares Rocket 91%
Reuters·03/26 08:31
BIOCYTOGEN PHARMACEUTICALS BEIJING FY GROSS MARGIN 77.7%
Reuters·12/16/2024 10:00
BIOCYTOGEN ANNOUNCES ADCENDO APS EXERCISES ANTIBODY OPTION TO ACCELERATE ADC DEVELOPMENT
Simply Wall St·12/12/2024 22:40
Health Check: How Prudently Does Biocytogen Pharmaceuticals (Beijing) (HKG:2315) Use Debt?
Simply Wall St·10/13/2024 23:01
Top SEHK Growth Companies With High Insider Ownership In October 2024
Simply Wall St·09/20/2024 09:06
High Growth Tech Stocks To Watch In Hong Kong This September 2024
Reuters·08/28/2024 11:46
BIOCYTOGEN PHARMACEUTICALS BEIJING H1 GROSS MARGIN 74.4%
Simply Wall St·08/22/2024 09:05
Top 3 High Growth Tech Stocks In Hong Kong To Watch
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.